Skip to main content
Log in

The influence of thyroid disorders on the dopaminergic regulation of prolactin, thyrotropin and growth hormone

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

In order to clarify if hyper-and hypothyroidism change by feed-back mechanisms the dopaminergic controlled release of PRL, TSH and GH, the serum values of these hormones were measured before and following iv administration of 5 mg metoclopramide in 10 hyperthyroid, 11 euthyroid and 10 primary hypothyroid age-matched females, all consecutively investigated. The secretion pattern, as well as the quantitated response (area under the curve AUC) of PRL were identical for the three groups, and uninfluenced by thyroid status. By contrast the TSH responses (AUC) were significantly and positively correlated to the basal TSH, suggesting that the effect of metoclopramide was dependent on the secretory capacity of the thyrotropic cells. The serum GH level was found to decrease in all three groups following metoclopramide, probably due to the inhibition of release. Stimulation of the same subjects with 200 μg TRH iv resulted in response curves of serum PRL and TSH, which were significantly and positively correlated to the basal serum TSH. The serum values of GH increased following TRH in the hypothyroid group, while the values of the hyperthyroid were depressed and unchanged. The present results suggest that the dopaminergic tonus on PRL, TSH and GH secretion is unaffected by thyroid feed-back mechanisms. The TRH-induced release of each of the three hormones is, however, dependent on thyroid status.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Suter S.N., Kaplan S.L, Aubert M.L., Grumbach M.M. Plasma prolactin and thyrotropin and the responses to thyrotropin-releasing factor in children with primary and hypothalamic hypothyroidism. J. Clin. Endocrinol. Metab. 47: 1015, 1978.

    Article  PubMed  CAS  Google Scholar 

  2. Snyder P.J., Jacobs L.S., Utiger R.D., Daughaday W.H. Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. J. Clin. Invest. 52: 2324, 1973.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  3. Thorner M.O. Prolactin. In: Besser G.M. (Ed.), The hypothalamus and pituitary. Clin. Endocrinol. Metab. 6: 201, 1977.

    Article  PubMed  CAS  Google Scholar 

  4. Kirkegaard C. The thyrotropin response to thyrotropin-releasing hormone in endogenous depression. Psychoneuroendocrinology 6: 189, 1981.

    Article  PubMed  CAS  Google Scholar 

  5. Eskildsen P.C., Svendsen P.Aa., Vang L., Nerup J. Long-term treatment of acromegaly with bromocriptine. Acta Endocrinol. (Kbh.) 87: 687, 1978.

    CAS  Google Scholar 

  6. Frantz A.G. Prolactin. N. Engl. J. Med. 298: 201, 1978.

    Article  PubMed  CAS  Google Scholar 

  7. Semples C.G., Beastall G.H., Teasdale G., Thomson J.A. Hypothyroidism presenting with hyperprolactinemia. Br. Med. J. 286: 1200, 1983.

    Article  Google Scholar 

  8. Malarkey W.B., Bech P. Twenty-four-hour prolactin profiles in normal and disease states. Failure of thyroxine to modify prolactin secretion. J. Clin. Endocrinol. Metab. 40: 708, 1975.

    Article  PubMed  CAS  Google Scholar 

  9. Contreras P., Generini G., Michelsen H., Pumarino M., Campino C. Hyperprolactinemia and galactorrhoea: Spontaneous versus iatrogenic hypothyroidism. J. Clin. Endocrinol. Metab. 53: 1036, 1981.

    Article  PubMed  CAS  Google Scholar 

  10. Delitala G., Deville L., Canessa A., D’Asta F. On the role of dopamine receptors in the central regulation of human TSH. Acta Endocrinol. (Kbh.) 98: 521, 1981.

    CAS  Google Scholar 

  11. Feek C.M., Sawers J.S.A., Brown N.S., Seth J., Irvine W.J., Toft A.D. Influence of thyroid status on dopaminergic inhibition of thyrotropin and prolactin secretion: Evidence for an additional feedback mechanism in the control of thyroid hormone secretion. J. Clin. Endocrinol. Metab. 51: 585, 1980.

    Article  PubMed  CAS  Google Scholar 

  12. Sawers J.S.A., Kellett H.A., Brown N.S., Seth J., Toft A.D. Prolactin response to metoclopramide in hypothyroidism. J. Clin. Endocrinol. Metab. 55: 175, 1982.

    Article  PubMed  CAS  Google Scholar 

  13. Scanlon M.F., Pourmand M., Mc Gregor A.M., RodriguezArnao M.D., Hall K., Gomez-Pan A., Hall R. Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin. J. Endocrinol. Invest. 2: 307, 1979.

    Article  PubMed  CAS  Google Scholar 

  14. Collu R., Lebouf G., Letarte J., Ducharme J.-R. Increase in plasma growth hormone levels following thyrotropin-releasing hormone injection in children with primary hypothyroidism. J. Clin. Endocrinol. Metab. 44: 743, 1977.

    Article  PubMed  CAS  Google Scholar 

  15. Hedlund L., Doelger S.G., Tollerton A.J., Lischoko M.M., Johnson H.D. Plasma growth hormone concentration after cerebro-ventricular and jugular injection of thyrotropin-releasing hormone. Proc. Soc. Exp. Biol. Med. 156: 422, 1973.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eskildsen, P.C., Kirkegaard, C.B. The influence of thyroid disorders on the dopaminergic regulation of prolactin, thyrotropin and growth hormone. J Endocrinol Invest 8, 427–431 (1985). https://doi.org/10.1007/BF03348530

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03348530

Key-words

Navigation